Taro Pharmaceutical Indu... TARO Income Statements

Conto economico

Quarter End	Giu 2022	Set 2022	Dic 2022	Mar 2023	Giu 2023	Set 2023	Dic 2023	Mar 2024
	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)
Entrate totali	156,67M	130,5M	139,2M	146,59M	158,89M	148,2M	157,15M	164,94M
Reddito operativo	13,98M	-6,82M	1,28M	9,27M	-7,92M	4,74M	15,91M	8,79M
Reddito ante imposte	16,05M	-4,91M	9,17M	17,9M	5,44M	17,66M	33,34M	26,23M
Reddito netto	14,08M	-2,81M	7,27M	6,91M	10,03M	8,55M	20,21M	15,08M
Dividendi preferiti	0	0	0	0	0	0	0	0
Utile base per azione (EPS)	0	0	0	0	0	0	0	0
UTILE OPERATIVO	14,42M	-6,42M	1,84M	10,33M	-7,53M	5,31M	17,73M	10,98M
EBITDA	20,95M	201k	8,61M	20,08M	-30k	12,35M	23,28M	17,01M

Fine anno 31 Marzo 2024	2017	2018	2019	2020	2021	2022	2023	2024
	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)
Entrate totali	879,39M	661,91M	673,57M	644,77M	548,97M	561,35M	572,95M	629,18M
Reddito operativo	514,95M	303,01M	296,19M	246,54M	-413,78M	63,47M	17,71M	21,51M
Reddito ante imposte	560,8M	292,37M	356,85M	298,04M	-391,07M	77,86M	38,21M	82,67M
Reddito netto	456,36M	211,15M	281,78M	244,24M	-386,65M	58,27M	25,45M	53,87M
Dividendi preferiti	0	0	0	0	0	0	0	0
Utile base per azione (EPS)	11.264	5.355	7.311	6.384	-10.194	1.55	0.677	1.433
UTILE OPERATIVO	526,16M	304,9M	298M	249,55M	-410,88M	67,7M	20,18M	26,49M
EBITDA	530,06M	319,51M	314,79M	267,92M	-390,1M	89,39M	49,85M	52,6M